immunotherapy

closed shuttered shut down closed

Biotech

Adecto blames ‘risk-adverse funding environment’ for closing

Adecto’s 12-year story has come to an end as the immunotherapy biotech blamed a “risk-averse funding environment” for shutting up shop.

James Waldron Oct 2, 2026 3:53am

man with skin cancer on head

Highlight Therapeutics illuminates positive data in skin cancer

Sep 30, 2026 9:00am

pipeline pipes RD research

PDS halts ph. 3 cancer therapy to focus on colorectal contender

Aug 13, 2026 9:55am

Cancer mutation precision medicine oncology targeted

BIO 2026: How a gut feeling transformed cancer treatment forever

Jun 25, 2026 9:23am

Person throwing piece of paper into full waste bin

Fierce Pharma

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am

Golfer devastated after just barely missing a putt

Immutep's ph. 3 failure surprises analysts, sinks stock

Mar 13, 2026 9:53am